Table 3. Comparison between autologous and allogeneic transplantation measured by the Quality of Life Questionnaire - Core 30 questionnaire and the Functional Assessment of Cancer Therapy - Bone Marrow Transplantation in the six stages of the research. Curitiba, PR, Brazil, 2013-2016 (n=55).

Domain	Before HSCT* (n=55)	Pancytopenia (n=50)	Before discharge (n=49)	After 100 days (n=41)	After 180 days (n=38)	After 360 days (n=32)
	p-value	p-value	p-value	p-value	p-value	p-value
Quality of Life Questionnaire - Core 30
Overall QoL†	0.094	0.571	0.266	0.298	0.841	0.785
Physical function	0.503	0.337	0.075	0.353	0.792	0.969
Personal Performance	0.993	0.251	0.428	0.249	0.312	0.611
Social role	0.213	0.099	0.223	0.186	0.207	0.639
Fatigue	0.905	0.369	0.325	0.836	0.525	0.289
Nausea and vomiting	0.847	0.750	0.924	0.151	0.841	0.815
Pain	0.052	0.004‡	0.285	0.480	0.359	0.180
Loss of appetite	0.734	0.297	0.240	0.031‡	0.938	0.755
Diarrhea	0.862	0.688	0.576	0.688	0.653	0.155
Functional Assessment of Cancer Therapy Bone Marrow Transplantation
Physical well-being	0.250	0.278	0.620	0.382	0.792	0.852
Functional well-being	0.790	0.658	0.240	0.031‡	0.699	0.348
Additional concerns	0.491	0.734	0.428	0.151	0.327	0.884
FACTG§	0.804	0.297	0.506	0.186	0.676	0.574
Overall QoL†	0.666	0.688	0.506	0.205	0.545	0.519

Notes: Mann-Whitney test; *HSCT: Hematopoietic stem cell transplantation; †QoL: Quality of life; ‡Statistically significant data; §FACTG: Overall assessment (physical well-being/social and family well-being/emotional well-being/functional well-being)